The incidence of recurrent toxoplasmosis retinochoroiditis within 12 months was 0 of 46 ( 0 % ) and 6 of 47 ( 12.80 % ) in the trimethoprim-sulfamethoxazole and placebo groups , respectively ( P = .026 ) .